Transcriptomic Analysis Brings New Insight Into the Biological Role of the Prion Protein During Mouse Embryogenesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Significance of the Evolutionary Relationship of Prion Proteins and ZIP Transporters in Health and Disease
The Significance of the Evolutionary Relationship of Prion Proteins and ZIP Transporters in Health and Disease by Sepehr Ehsani A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Laboratory Medicine and Pathobiology University of Toronto © Copyright by Sepehr Ehsani 2012 The Significance of the Evolutionary Relationship of Prion Proteins and ZIP Transporters in Health and Disease Sepehr Ehsani Doctor of Philosophy Department of Laboratory Medicine and Pathobiology University of Toronto 2012 Abstract The cellular prion protein (PrPC) is unique amongst mammalian proteins in that it not only has the capacity to aggregate (in the form of scrapie PrP; PrPSc) and cause neuronal degeneration, but can also act as an independent vector for the transmission of disease from one individual to another of the same or, in some instances, other species. Since the discovery of PrPC nearly thirty years ago, two salient questions have remained largely unanswered, namely, (i) what is the normal function of the cellular protein in the central nervous system, and (ii) what is/are the factor(s) involved in the misfolding of PrPC into PrPSc? To shed light on aspects of these questions, we undertook a discovery-based interactome investigation of PrPC in mouse neuroblastoma cells (Chapter 2), and among the candidate interactors, identified two members of the ZIP family of zinc transporters (ZIP6 and ZIP10) as possessing a PrP-like domain. Detailed analyses revealed that the LIV-1 subfamily of ZIP transporters (to which ZIPs 6 and 10 belong) are in fact the evolutionary ancestors of prions (Chapter 3). -
Endothelial LRP1 Transports Amyloid-Β1–42 Across the Blood- Brain Barrier
Endothelial LRP1 transports amyloid-β1–42 across the blood- brain barrier Steffen E. Storck, … , Thomas A. Bayer, Claus U. Pietrzik J Clin Invest. 2016;126(1):123-136. https://doi.org/10.1172/JCI81108. Research Article Neuroscience According to the neurovascular hypothesis, impairment of low-density lipoprotein receptor–related protein-1 (LRP1) in brain capillaries of the blood-brain barrier (BBB) contributes to neurotoxic amyloid-β (Aβ) brain accumulation and drives Alzheimer’s disease (AD) pathology. However, due to conflicting reports on the involvement of LRP1 in Aβ transport and the expression of LRP1 in brain endothelium, the role of LRP1 at the BBB is uncertain. As global Lrp1 deletion in mice is lethal, appropriate models to study the function of LRP1 are lacking. Moreover, the relevance of systemic Aβ clearance to AD pathology remains unclear, as no BBB-specific knockout models have been available. Here, we developed transgenic mouse strains that allow for tamoxifen-inducible deletion of Lrp1 specifically within brain endothelial cells (Slco1c1- CreERT2 Lrp1fl/fl mice) and used these mice to accurately evaluate LRP1-mediated Aβ BBB clearance in vivo. Selective 125 deletion of Lrp1 in the brain endothelium of C57BL/6 mice strongly reduced brain efflux of injected [ I] Aβ1–42. Additionally, in the 5xFAD mouse model of AD, brain endothelial–specific Lrp1 deletion reduced plasma Aβ levels and elevated soluble brain Aβ, leading to aggravated spatial learning and memory deficits, thus emphasizing the importance of systemic Aβ elimination via the BBB. Together, our results suggest that receptor-mediated Aβ BBB clearance may be a potential target for treatment and prevention of Aβ brain accumulation in AD. -
The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring
cells Review The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring Kamila Puchałowicz * and Monika Ewa Ra´c Department of Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland; [email protected] * Correspondence: [email protected] Received: 2 July 2020; Accepted: 9 August 2020; Published: 11 August 2020 Abstract: CD36 is a multiligand receptor contributing to glucose and lipid metabolism, immune response, inflammation, thrombosis, and fibrosis. A wide range of tissue expression includes cells sensitive to metabolic abnormalities associated with metabolic syndrome and diabetes mellitus (DM), such as monocytes and macrophages, epithelial cells, adipocytes, hepatocytes, skeletal and cardiac myocytes, pancreatic β-cells, kidney glomeruli and tubules cells, pericytes and pigment epithelium cells of the retina, and Schwann cells. These features make CD36 an important component of the pathogenesis of DM and its complications, but also a promising target in the treatment of these disorders. The detrimental effects of CD36 signaling are mediated by the uptake of fatty acids and modified lipoproteins, deposition of lipids and their lipotoxicity, alterations in insulin response and the utilization of energy substrates, oxidative stress, inflammation, apoptosis, and fibrosis leading to the progressive, often irreversible organ dysfunction. This review summarizes the extensive knowledge of the contribution of CD36 to DM and its complications, including nephropathy, -
Guidelines for PRNP Genetic Testing Document Number: 2019PS03 Publication Date: 12 2019 Replaces: New Review Date: 12 2023
HUMAN GENETICS SOCIETY OF AUSTRALASIA ARBN. 076 130 937 (Incorporated Under the Associations Incorporation Act) The liability of members is limited PO Box 6012, Alexandria, NSW 2015 ABN No. 17 076 130 937 Telephone: 02 9669 6602 Fax: 02 9669 6607 Email: [email protected] Position Statement Title: Guidelines for PRNP genetic testing Document Number: 2019PS03 Publication Date: 12 2019 Replaces: New Review Date: 12 2023 Guidelines for PRNP genetic testing I. PREFACE The following guidelines are recommended procedures and should be viewed as a framework of recommended procedures, not regulations. The recommendations concern the use of genetic testing for the detection of mutations in the prion protein gene (PRNP) and are intended for use by healthcare providers assisting families affected by or suspected to be affected by prion disease and to assist at-risk individuals and those who chose to be tested. These guidelines have been developed by a committee consisting of representatives of clinical genetic services, genetic testing laboratories, the CJD Support Group Network (CJDSGN) and the Australian National Creutzfeldt-Jakob Disease Registry (ANCJDR). Feedback and information from the New Zealand CJD Register, Human Genetics Society of Australasia and Genetic Services is incorporated. A lay version of the guidelines can be requested directly from the CJDSGN and ANCJDR or downloaded from links below, to ensure that patient families are able to make independent informed decisions. www.florey.edu.au/science-research/scientific-services-facilities/australian-national-cjd-registry/cjd- diagnostic-tests - PRNP www.cjdsupport.org.au/site/wp-content/uploads/2019/08/PRNP-Guidelines-final-.pdf 1 II. -
In Vitro Selection for Adhesion of Plasmodium Falciparum-Infected Erythrocytes to ABO Antigens Does Not Affect Pfemp1 and RIFIN
www.nature.com/scientificreports OPEN In vitro selection for adhesion of Plasmodium falciparum‑infected erythrocytes to ABO antigens does not afect PfEMP1 and RIFIN expression William van der Puije1,2, Christian W. Wang 4, Srinidhi Sudharson 2, Casper Hempel 2, Rebecca W. Olsen 4, Nanna Dalgaard 4, Michael F. Ofori 1, Lars Hviid 3,4, Jørgen A. L. Kurtzhals 2,4 & Trine Staalsoe 2,4* Plasmodium falciparum causes the most severe form of malaria in humans. The adhesion of the infected erythrocytes (IEs) to endothelial receptors (sequestration) and to uninfected erythrocytes (rosetting) are considered major elements in the pathogenesis of the disease. Both sequestration and rosetting appear to involve particular members of several IE variant surface antigens (VSAs) as ligands, interacting with multiple vascular host receptors, including the ABO blood group antigens. In this study, we subjected genetically distinct P. falciparum parasites to in vitro selection for increased IE adhesion to ABO antigens in the absence of potentially confounding receptors. The selection resulted in IEs that adhered stronger to pure ABO antigens, to erythrocytes, and to various human cell lines than their unselected counterparts. However, selection did not result in marked qualitative changes in transcript levels of the genes encoding the best-described VSA families, PfEMP1 and RIFIN. Rather, overall transcription of both gene families tended to decline following selection. Furthermore, selection-induced increases in the adhesion to ABO occurred in the absence of marked changes in immune IgG recognition of IE surface antigens, generally assumed to target mainly VSAs. Our study sheds new light on our understanding of the processes and molecules involved in IE sequestration and rosetting. -
Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened. -
Strain-Specific Innate Immune Signaling Pathways Determine
Strain-specific innate immune signaling pathways PNAS PLUS determine malaria parasitemia dynamics and host mortality Jian Wua, Linjie Tianb,1, Xiao Yuc,d,1, Sittiporn Pattaradilokrata,e, Jian Lia,f, Mingjun Wangc, Weishi Yug, Yanwei Qia,f, Amir E. Zeitunia, Sethu C. Naira, Steve P. Cramptonb, Marlene S. Orandleh, Silvia M. Bollandb, Chen-Feng Qib, Carole A. Longa, Timothy G. Myersi, John E. Coliganb, Rongfu Wangc,2, and Xin-zhuan Sua,2 aLaboratory of Malaria and Vector Research, and bLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; cCenter for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX 77030; dState Key Laboratory of Biocontrol and Key Laboratory of Gene Engineering of Ministry of Education, Sun Yat-sen University, Guangzhou 510006, People’s Republic of China; eDepartment of Biology, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand; fState Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian 361005, People’s Republic of China; gLaboratory of Cancer Prevention, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD 21702; and hComparative Medicine Branch, iGenomic Technologies Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 Edited by Fidel Zavala, The Johns Hopkins University School of Public Health, Baltimore, MD, and accepted by the Editorial Board December 18, 2013 (received for review September 2, 2013) Malaria infection triggers vigorous host immune responses; how- (TLRs) and scavenger receptors have been implicated in the re- ever, the parasite ligands, host receptors, and the signaling path- sponse to malaria infection and for triggering proinflammatory ways responsible for these reactions remain unknown or responses (4, 8–15); however, other studies indicated that TLR- controversial. -
Multiomics of Azacitidine-Treated AML Cells Reveals Variable And
Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome Kevin K. Leunga, Aaron Nguyenb, Tao Shic, Lin Tangc, Xiaochun Nid, Laure Escoubetc, Kyle J. MacBethb, Jorge DiMartinob, and James A. Wellsa,1 aDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143; bEpigenetics Thematic Center of Excellence, Celgene Corporation, San Francisco, CA 94158; cDepartment of Informatics and Predictive Sciences, Celgene Corporation, San Diego, CA 92121; and dDepartment of Informatics and Predictive Sciences, Celgene Corporation, Cambridge, MA 02140 Contributed by James A. Wells, November 19, 2018 (sent for review August 23, 2018; reviewed by Rebekah Gundry, Neil L. Kelleher, and Bernd Wollscheid) Myelodysplastic syndromes (MDS) and acute myeloid leukemia of DNA methyltransferases, leading to loss of methylation in (AML) are diseases of abnormal hematopoietic differentiation newly synthesized DNA (10, 11). It was recently shown that AZA with aberrant epigenetic alterations. Azacitidine (AZA) is a DNA treatment of cervical (12, 13) and colorectal (14) cancer cells methyltransferase inhibitor widely used to treat MDS and AML, can induce interferon responses through reactivation of endoge- yet the impact of AZA on the cell-surface proteome has not been nous retroviruses. This phenomenon, termed viral mimicry, is defined. To identify potential therapeutic targets for use in com- thought to induce antitumor effects by activating and engaging bination with AZA in AML patients, we investigated the effects the immune system. of AZA treatment on four AML cell lines representing different Although AZA treatment has demonstrated clinical benefit in stages of differentiation. The effect of AZA treatment on these AML patients, additional therapeutic options are needed (8, 9). -
Southeast Asian Ovalocytosis Is Associated with Increased Expression of Duffy Antigen Receptor for Chemokines (DARC)
Original Report Southeast Asian ovalocytosis is associated with increased expression of Duffy antigen receptor for chemokines (DARC) I.J. Woolley, P. Hutchinson, J.C. Reeder, J.W. Kazura, and A. Cortés The Duffy antigen receptor for chemokines (DARC or Fy glyco- RBC morphology.3 SAO is widespread in several popula- protein) carries antigens that are important in blood transfusion tions of Papua New Guinea (PNG), where its prevalence and is the main receptor used by Plasmodium vivax to invade correlates with malaria endemicity and altitude.4 In these reticulocytes. Southeast Asian ovalocytosis (SAO) results from populations, homozygosity is apparently incompatible with an alteration in RBC membrane protein band 3 and is thought to full development of the fetus inasmuch as no persons ho- mitigate susceptibility to falciparum malaria. Expression of some RBC antigens is suppressed by SAO, and we hypothesized that mozygous for the band 3 mutation have yet been described, SAO may also reduce Fy expression, potentially leading to reduced but heterozygosity confers strong protection against cere- susceptibility to vivax malaria. Blood samples were collected from bral malaria.5,6 Although early studies had suggested that individuals living in the Madang Province of Papua New Guinea. the SAO trait may afford some protection against vivax or Samples were assayed using a flow cytometry assay for expres- falciparum parasitemia,7–9 other studies did not support sion of Fy on the surface of RBC and reticulocytes by measuring this hypothesis.10 The mechanism of protection against the attachment of a phycoerythrin-labeled Fy6 antibody. Reticu- cerebral malaria is not completely understood,11,12 but the locytes were detected using thiazole orange. -
Unaltered Intravenous Prion Disease Pathogenesis in the Temporary Absence of Marginal Zone B Cells Barry M
www.nature.com/scientificreports OPEN Unaltered intravenous prion disease pathogenesis in the temporary absence of marginal zone B cells Barry M. Bradford & Neil A. Mabbott * Prion diseases are a unique, infectious, neurodegenerative disorders that can afect animals and humans. Data from mouse transmissions show that efcient infection of the host after intravenous (IV) prion exposure is dependent upon the early accumulation and amplifcation of the prions on stromal follicular dendritic cells (FDC) in the B cell follicles. How infectious prions are initially conveyed from the blood-stream to the FDC in the spleen is uncertain. Addressing this issue is important as susceptibility to peripheral prion infections can be reduced by treatments that prevent the early accumulation of prions upon FDC. The marginal zone (MZ) in the spleen contains specialized subsets of B cells and macrophages that are positioned to continuously monitor the blood-stream and remove pathogens, toxins and apoptotic cells. The continual shuttling of MZ B cells between the MZ and the B-cell follicle enables them to efciently capture and deliver blood-borne antigens and antigen-containing immune complexes to splenic FDC. We tested the hypothesis that MZ B cells also play a role in the initial shuttling of prions from the blood-stream to FDC. MZ B cells were temporarily depleted from the MZ by antibody-mediated blocking of integrin function. We show that depletion of MZ B cells around the time of IV prion exposure did not afect the early accumulation of blood-borne prions upon splenic FDC or reduce susceptibility to IV prion infection. In conclusion, our data suggest that the initial delivery of blood-borne prions to FDC in the spleen occurs independently of MZ B cells. -
Scavenger Receptor CD36 Is Essential for the Cerebrovascular Oxidative Stress and Neurovascular Dysfunction Induced by Amyloid-Β
Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-β Laibaik Parka, Gang Wanga, Ping Zhoua, Joan Zhoua, Rose Pitstickb, Mary Lou Previtic, Linda Younkind, Steven G. Younkind, William E. Van Nostrandc, Sunghee Choe, Josef Anrathera, George A. Carlsonb, and Costantino Iadecolaa,1 aDivision of Neurobiology, Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, NY 10065; bMcLaughlin Research Institute, Great Falls, MT 56405; cDepartment of Neurosurgery, Stony Brook University, Stony Brook, NY 11794; dMayo Clinic Jacksonville, Jacksonville, FL 32224; and eDepartment of Neurology and Neuroscience, Weill Medical College of Cornell University, Burke Rehabilitation Center, White Plains, NY 10605 Edited by Thomas C. Südhof, Stanford University School of Medicine, Palo Alto, CA, and approved February 8, 2011 (received for review October 14, 2010) Increasing evidence indicates that cerebrovascular dysfunction anisms ensure that the brain receives a sufficient amount of plays a pathogenic role in Alzheimer’s dementia (AD). Amyloid-β blood flow at all times (9). For example, functional hyperemia (Aβ), a peptide central to the pathogenesis of AD, has profound matches the delivery of blood flow with the metabolic demands vascular effects mediated, for the most part, by reactive oxygen imposed by neural activity, whereas vasoactive agents released species produced by the enzyme NADPH oxidase. The mechanisms from endothelial cells regulate microvascular flow (9). Aβ1–40, β linking A to NADPH oxidase-dependent vascular oxidative stress but not Aβ1–42, disrupts these vital homeostatic mechanisms, have not been identified, however. We report that the scavenger leading to neurovascular dysfunction and increasing the suscep- receptor CD36, a membrane glycoprotein that binds Aβ, is essen- tibility of the brain to injury (3). -
(RACK1) Protein
ANTICANCER RESEARCH 26: 4539-4548 (2006) The Prion-like Protein Doppel (Dpl) Interacts with the Human Receptor for Activated C-Kinase 1 (RACK1) Protein ALBERTO AZZALIN, IGOR DEL VECCHIO, LUCA FERRETTI and SERGIO COMINCINI Dipartimento di Genetica e Microbiologia, Università di Pavia, via Ferrata 1, 27100 Pavia, Italy Abstract. Background: Doppel (Dpl) is a homologue of the expressed in the testis, especially in Sertoli cells and in prion protein (PrPC). In contrast to PrPC, Dpl is dispensable for spermatozoa, and its involvement in male fertility has been prion disease, but appears to have an essential function in male recently proposed (4, 5). NMR studies of Dpl have revealed a spermatogenesis. Recently, Dpl has been found to be aberrantly high structural similarity with the prion protein (PrPC) (6, 7), expressed in astrocytic and leukaemic tumor specimens, showing which supported the possibility that the two proteins share a peculiar cytosolic cellular localization. The aim of this study similar functions in vivo. Despite a multitude of studies, the was to clarify some of the putative Dpl interacting proteins. cellular functions of Dpl and PrPC are still unknown. However, Materials and Methods: A yeast two hybrid system was employed current data suggested that Dpl, unlike PrPC, is probably not and the results were verified by co-immunoprecipitation using required for the pathogenesis of prion diseases (8, 9) and is not transfected cells. Results: Several potential Dpl-binding converted into a PrPSc-like isoform (10, 11). Importantly, Dpl candidates were identified and, among them, the receptor for can cause Purkinje cell death and ataxia when over-expressed activated C-kinase (RACK1) protein was further investigated.